Notice: Global Information Announces Listing on JASDAQ Standard Market of the Tokyo Stock Exchange

Cover Image
Market Research Report

Global Sleep Apnea Therapeutics and Diagnostics Market Forecast 2021-2028

Published by Inkwood Research Product code 1018670
Published Content info 263 Pages
Delivery time: 2-3 business days
Price
Back to Top
Global Sleep Apnea Therapeutics and Diagnostics Market Forecast 2021-2028
Published: July 19, 2021 Content info: 263 Pages
Description

KEY FINDINGS

The global sleep apnea therapeutics and diagnostics market is anticipated to grow at a CAGR of 6.78% during the forecast period, 2021-2028. The increasing sleep apnea incidences, rising geriatric population, growing obesity, technological advancements, etc., propel market growth.

MARKET INSIGHTS

Sleep apnea is a sleep disorder wherein the patient's breathing patterns stop or decrease during sleep. The pause can last 10 seconds or longer. It can also occur up to 30 times in an hour. Loud snoring, restless sleep, and daytime sleepiness are the symptoms of sleep apnea. Since the 1990s, the prevalence of sleep apnea has been increasing significantly. Though the diagnosis rate is very low. For instance, as per the Canadian Medical Association Journal (CMAJ) study of December 2017, around 3%-50% of adults had sleep apnea. Out of which, only 3% had the disease clinically diagnosed. Undiagnosed sleep apnea can lead to chronic conditions like depression, cognitive impairment, metabolic disorders, and cardiovascular diseases. Also, sleep apnea can aggravate the risk of motor accidents and mortality rates.

Furthermore, several regional associations like the Indian Association of Surgeons for Sleep Apnea, Canadian Sleep Society, and America Sleep Apnea Association (ASAA) spread awareness about sleep apnea. Further, organizations are encouraging research in sleep medicines and conducting seminars for bringing the patient and physicians on the same platform. Moreover, the increasing awareness about the ill effects of untreated sleep apnea has raised the adoption of sleep apnea devices like Actigraphy devices, sleep testing devices, portable treatment devices, etc. Such factors drive market growth.

REGIONAL INSIGHTS

The global sleep apnea therapeutics and diagnostics market growth evaluation includes the analysis of North America, Asia-Pacific, Europe, and Rest of World. Government initiatives and technological advancements contribute to the market prospects of North America. It is the dominating region in the global market with the highest revenue.

COMPETITIVE INSIGHTS

The moderately intense rivalry in the market includes new entrants and local players putting pressure on the existing players. Some of the prominent companies in the market include BMC Medical Co Ltd, Invacare Corporation, Itamar Medical Ltd, GE Healthcare, Braebon Medical Corporation, etc.

Our report offerings include:

  • Explore key findings of the overall market
  • Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
  • Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
  • Market Segmentation cater to a thorough assessment of key segments with their market estimations
  • Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
  • Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
  • Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
  • Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments
Table of Contents
Product Code: 24143

TABLE OF CONTENTS

1. RESEARCH SCOPE & METHODOLOGY

  • 1.1. STUDY OBJECTIVES
  • 1.2. SCOPE OF STUDY
  • 1.3. METHODOLOGY
  • 1.4. ASSUMPTIONS & LIMITATIONS

2. EXECUTIVE SUMMARY

  • 2.1. MARKET SIZE & ESTIMATES
  • 2.2. MARKET OVERVIEW

3. MARKET DYNAMICS

  • 3.1. KEY DRIVERS
    • 3.1.1. SURGING AGING POPULATION AND OBESITY
    • 3.1.2. AWARENESS OF ILL EFFECTS OF UNTREATED SLEEP APNEA
    • 3.1.3. SLEEP APNEA INCIDENCES
    • 3.1.4. DEMAND FOR PORTABLE SLEEP APNEA DEVICES
    • 3.1.5. TECHNOLOGICAL ADVANCEMENTS
  • 3.2. KEY RESTRAINTS
    • 3.2.1. HIGH COST OF SLEEP APNEA DEVICES
    • 3.2.2. LACK OF REIMBURSEMENTS
    • 3.2.3. DEARTH OF PATIENT COMPLIANCE

4. KEY ANALYTICS

  • 4.1. IMPACT OF COVID-19 ON SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET
  • 4.2. KEY MARKET TRENDS
  • 4.3. PORTER'S FIVE FORCES ANALYSIS
    • 4.3.1. BUYERS POWER
    • 4.3.2. SUPPLIERS POWER
    • 4.3.3. SUBSTITUTION
    • 4.3.4. NEW ENTRANTS
    • 4.3.5. INDUSTRY RIVALRY
  • 4.4. REGULATORY FRAMEWORK
    • 4.4.1. NORTH AMERICA
    • 4.4.2. EUROPE
    • 4.4.3. ASIA-PACIFIC
  • 4.5. SUPPLY CHAIN ANALYSIS
  • 4.6. OPPORTUNITY MATRIX
  • 4.7. VENDOR LANDSCAPE

5. MARKET BY PRODUCT TYPE

  • 5.1. THERAPEUTICS
    • 5.1.1. POSITIVE AIRWAY PRESSURE (PAP) DEVICES
      • 5.1.1.1. CONTINUOUS POSITIVE AIRWAY PRESSURE (CPAP) DEVICES
      • 5.1.1.2. BILEVEL POSITIVE AIRWAY PRESSURE (BPAP) DEVICES
    • 5.1.2. OXYGEN DEVICES
      • 5.1.2.1. OXYGEN CONCENTRATORS
      • 5.1.2.2. PORTABLE OXYGEN CONCENTRATORS
      • 5.1.2.3. LIQUID PORTABLE OXYGEN
    • 5.1.3. MASKS AND ACCESSORIES
    • 5.1.4. ORAL APPLIANCES
      • 5.1.4.1. MANDIBULAR ADVANCEMENT DEVICES
      • 5.1.4.2. TONGUE RETAINERS
    • 5.1.5. ADAPTIVE SERVO VENTILATION (ASV) DEVICES
  • 5.2. DIAGNOSTICS AND MONITORING
    • 5.2.1. POLYSOMNOGRAPHY DEVICE (PSG)
      • 5.2.1.1. CLINICAL PSG DEVICE
      • 5.2.1.2. AMBULATORY PSG DEVICE
    • 5.2.2. OXIMETER
      • 5.2.2.1. TABLETOP OXIMETER
      • 5.2.2.2. FINGERTIP OXIMETER
      • 5.2.2.3. HANDHELD OXIMETER
      • 5.2.2.4. WRIST-WORN OXIMETER
    • 5.2.3. ACTIGRAPHY MONITORING DEVICE
    • 5.2.4. RESPIRATORY POLYGRAPH
    • 5.2.5. SLEEP APNEA SCREENING DEVICE
    • 5.2.6. OTHER DIAGNOSTICS AND MONITORING DEVICES

6. MARKET BY END-USER

  • 6.1. HOSPITALS & SLEEP LABORATORIES
  • 6.2. HOME CARE SETTINGS

7. GEOGRAPHICAL ANALYSIS

  • 7.1. NORTH AMERICA
    • 7.1.1. MARKET SIZE & ESTIMATES
    • 7.1.2. KEY GROWTH ENABLERS
    • 7.1.3. KEY CHALLENGES
    • 7.1.4. KEY PLAYERS
    • 7.1.5. COUNTRY ANALYSIS
      • 7.1.5.1. UNITED STATES
      • 7.1.5.2. CANADA
  • 7.2. EUROPE
    • 7.2.1. MARKET SIZE & ESTIMATES
    • 7.2.2. KEY GROWTH ENABLERS
    • 7.2.3. KEY CHALLENGES
    • 7.2.4. KEY PLAYERS
    • 7.2.5. COUNTRY ANALYSIS
      • 7.2.5.1. GERMANY
      • 7.2.5.2. FRANCE
      • 7.2.5.3. UNITED KINGDOM
      • 7.2.5.4. ITALY
      • 7.2.5.5. RUSSIA
      • 7.2.5.6. BELGIUM
      • 7.2.5.7. POLAND
      • 7.2.5.8. REST OF EUROPE
  • 7.3. ASIA-PACIFIC
    • 7.3.1. MARKET SIZE & ESTIMATES
    • 7.3.2. KEY GROWTH ENABLERS
    • 7.3.3. KEY CHALLENGES
    • 7.3.4. KEY PLAYERS
    • 7.3.5. COUNTRY ANALYSIS
      • 7.3.5.1. CHINA
      • 7.3.5.2. JAPAN
      • 7.3.5.3. AUSTRALIA & NEW ZEALAND
      • 7.3.5.4. INDIA
      • 7.3.5.5. SOUTH KOREA
      • 7.3.5.6. THAILAND
      • 7.3.5.7. INDONESIA
      • 7.3.5.8. VIETNAM
      • 7.3.5.9. REST OF ASIA-PACIFIC
  • 7.4. REST OF WORLD
    • 7.4.1. MARKET SIZE & ESTIMATES
    • 7.4.2. KEY GROWTH ENABLERS
    • 7.4.3. KEY CHALLENGE
    • 7.4.4. KEY PLAYERS
    • 7.4.5. REGIONAL ANALYSIS
      • 7.4.5.1. LATIN AMERICA
      • 7.4.5.2. MIDDLE EAST & AFRICA

8. COMPETITIVE LANDSCAPE

  • 8.1. KEY STRATEGIC DEVELOPMENTS
    • 8.1.1. MERGERS & ACQUISITIONS
    • 8.1.2. PRODUCT LAUNCHES & DEVELOPMENTS
    • 8.1.3. PARTNERSHIPS & AGREEMENTS
    • 8.1.4. BUSINESS EXPANSIONS & DIVESTITURES
  • 8.2. COMPANY PROFILES
    • 8.2.1. BMC MEDICAL CO LTD
    • 8.2.2. BRAEBON MEDICAL CORPORATION
    • 8.2.3. CADWELL INDUSTRIES INC
    • 8.2.4. DEVILBISS HEALTHCARE LLC
    • 8.2.5. FISHER & PAYKEL HEALTHCARE CORPORATION LIMITED
    • 8.2.6. GE HEALTHCARE
    • 8.2.7. INVACARE CORPORATION
    • 8.2.8. ITAMAR MEDICAL LTD
    • 8.2.9. KONINKLIJKE PHILIPS NV
    • 8.2.10. MEDTRONIC PLC
    • 8.2.11. NIHON KOHDEN CORPORATION
    • 8.2.12. RESMED INC
    • 8.2.13. SMITHS MEDICAL INC
    • 8.2.14. SOMNOMEDICS GMBH
    • 8.2.15. TELEFLEX INCORPORATED
    • 8.2.16. VYAIRE MEDICAL INC

LIST OF TABLES

  • TABLE 1: MARKET SNAPSHOT - SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS
  • TABLE 2: NUMBER OF PERSONS AGED 65 YEARS OR OVER BY GEOGRAPHIC REGION, 2019 AND 2050
  • TABLE 3: GLOBAL SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET, BY PRODUCT TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 4: GLOBAL SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET, BY PRODUCT TYPE, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 5: GLOBAL THERAPEUTICS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 6: GLOBAL THERAPEUTICS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 7: GLOBAL THERAPEUTICS MARKET, BY TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 8: GLOBAL THERAPEUTICS MARKET, BY TYPE, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 9: GLOBAL POSITIVE AIRWAY PRESSURE (PAP) DEVICES MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 10: GLOBAL POSITIVE AIRWAY PRESSURE (PAP) DEVICES MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 11: GLOBAL POSITIVE AIRWAY PRESSURE (PAP) DEVICES MARKET, BY TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 12: GLOBAL POSITIVE AIRWAY PRESSURE (PAP) DEVICES MARKET, BY TYPE, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 13: GLOBAL OXYGEN DEVICES MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 14: GLOBAL OXYGEN DEVICES MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 15: GLOBAL OXYGEN DEVICES MARKET, BY TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 16: GLOBAL OXYGEN DEVICES MARKET, BY TYPE, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 17: GLOBAL MASKS AND ACCESSORIES MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 18: GLOBAL MASKS AND ACCESSORIES MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 19: GLOBAL ORAL APPLIANCES MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 20: GLOBAL ORAL APPLIANCES MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 21: GLOBAL ORAL APPLIANCES MARKET, BY TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 22: GLOBAL ORAL APPLIANCES MARKET, BY TYPE, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 23: GLOBAL ADAPTIVE SERVO VENTILATION (ASV) DEVICES MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 24: GLOBAL ADAPTIVE SERVO VENTILATION (ASV) DEVICES MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 25: GLOBAL DIAGNOSTICS AND MONITORING MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 26: GLOBAL DIAGNOSTICS AND MONITORING MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 27: GLOBAL DIAGNOSTICS AND MONITORING MARKET, BY TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 28: GLOBAL DIAGNOSTICS AND MONITORING MARKET, BY TYPE, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 29: GLOBAL POLYSOMNOGRAPHY DEVICE (PSG) MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 30: GLOBAL POLYSOMNOGRAPHY DEVICE (PSG) MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 31: GLOBAL POLYSOMNOGRAPHY DEVICE (PSG) MARKET, BY TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 32: GLOBAL POLYSOMNOGRAPHY DEVICE (PSG) MARKET, BY TYPE, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 33: GLOBAL OXIMETER MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 34: GLOBAL OXIMETER MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 35: GLOBAL OXIMETER MARKET, BY TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 36: GLOBAL OXIMETER MARKET, BY TYPE, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 37: GLOBAL ACTIGRAPHY MONITORING DEVICE MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 38: GLOBAL ACTIGRAPHY MONITORING DEVICE MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 39: GLOBAL RESPIRATORY POLYGRAPH MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 40: GLOBAL RESPIRATORY POLYGRAPH MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 41: GLOBAL SLEEP APNEA SCREENING DEVICE MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 42: GLOBAL SLEEP APNEA SCREENING DEVICE MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 43: GLOBAL OTHER DIAGNOSTICS AND MONITORING DEVICES MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 44: GLOBAL OTHER DIAGNOSTICS AND MONITORING DEVICES MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 45: GLOBAL SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET, BY END-USER, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 46: GLOBAL SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET, BY END-USER, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 47: GLOBAL HOSPITALS & SLEEP LABORATORIES MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 48: GLOBAL HOSPITALS & SLEEP LABORATORIES MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 49: GLOBAL HOME CARE SETTINGS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 50: GLOBAL HOME CARE SETTINGS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 51: GLOBAL SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET, BY REGION, HISTORIC YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 52: GLOBAL SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 53: NORTH AMERICA SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 54: NORTH AMERICA SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 55: LEADING PLAYERS OPERATING IN NORTH AMERICA SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET
  • TABLE 56: EUROPE SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 57: EUROPE SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 58: LEADING PLAYERS OPERATING IN EUROPE SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET
  • TABLE 59: ASIA-PACIFIC SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 60: ASIA-PACIFIC SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 61: LEADING PLAYERS OPERATING IN ASIA-PACIFIC SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET
  • TABLE 62: REST OF WORLD SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 63: REST OF WORLD SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 64: LEADING PLAYERS OPERATING IN REST OF WORLD SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET
  • TABLE 65: LIST OF MERGERS & ACQUISITIONS
  • TABLE 66: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
  • TABLE 67: LIST OF PARTNERSHIPS & AGREEMENTS
  • TABLE 68: LIST OF BUSINESS EXPANSIONS & DIVESTITURES

LIST OF FIGURES

  • FIGURE 1: ADVANTAGES OF PORTABLE CONTINUOUS POSITIVE AIRWAY PRESSURE DEVICES
  • FIGURE 2: KEY MARKET TRENDS
  • FIGURE 3: PORTER'S FIVE FORCES ANALYSIS
  • FIGURE 4: OPPORTUNITY MATRIX
  • FIGURE 5: VENDOR LANDSCAPE
  • FIGURE 6: GLOBAL SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET, BY PRODUCT TYPE, IN 2020
  • FIGURE 7: GLOBAL SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET, BY THERAPEUTICS, 2021-2028 (IN $ MILLION)
  • FIGURE 8: GLOBAL SLEEP APNEA THERAPEUTICS MARKET, BY POSITIVE AIRWAY PRESSURE (PAP) DEVICES, 2021-2028 (IN $ MILLION)
  • FIGURE 9: GLOBAL SLEEP APNEA THERAPEUTICS MARKET, BY CONTINUOUS POSITIVE AIRWAY PRESSURE (CPAP) DEVICES, 2021-2028 (IN $ MILLION)
  • FIGURE 10: GLOBAL SLEEP APNEA THERAPEUTICS MARKET, BY BILEVEL POSITIVE AIRWAY PRESSURE (BPAP) DEVICES, 2021-2028 (IN $ MILLION)
  • FIGURE 11: GLOBAL SLEEP APNEA THERAPEUTICS MARKET, BY OXYGEN DEVICES, 2021-2028 (IN $ MILLION)
  • FIGURE 12: GLOBAL SLEEP APNEA THERAPEUTICS MARKET, BY OXYGEN CONCENTRATORS, 2021-2028 (IN $ MILLION)
  • FIGURE 13: GLOBAL SLEEP APNEA THERAPEUTICS MARKET, BY PORTABLE OXYGEN CONCENTRATORS, 2021-2028 (IN $ MILLION)
  • FIGURE 14: GLOBAL SLEEP APNEA THERAPEUTICS MARKET, BY LIQUID PORTABLE OXYGEN, 2021-2028 (IN $ MILLION)
  • FIGURE 15: GLOBAL SLEEP APNEA THERAPEUTICS MARKET, BY MASKS AND ACCESSORIES, 2021-2028 (IN $ MILLION)
  • FIGURE 16: GLOBAL SLEEP APNEA THERAPEUTICS MARKET, BY ORAL APPLIANCES, 2021-2028 (IN $ MILLION)
  • FIGURE 17: GLOBAL SLEEP APNEA THERAPEUTICS MARKET, BY MANDIBULAR ADVANCEMENT DEVICES, 2021-2028 (IN $ MILLION)
  • FIGURE 18: GLOBAL SLEEP APNEA THERAPEUTICS MARKET, BY TONGUE RETAINERS, 2021-2028 (IN $ MILLION)
  • FIGURE 19: GLOBAL SLEEP APNEA THERAPEUTICS MARKET, BY ADAPTIVE SERVO VENTILATION (ASV) DEVICES, 2021-2028 (IN $ MILLION)
  • FIGURE 20: GLOBAL SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET, BY DIAGNOSTICS AND MONITORING, 2021-2028 (IN $ MILLION)
  • FIGURE 21: GLOBAL DIAGNOSTICS AND MONITORING MARKET, BY POLYSOMNOGRAPHY DEVICE (PSG), 2021-2028 (IN $ MILLION)
  • FIGURE 22: GLOBAL POLYSOMNOGRAPHY DEVICE (PSG) MARKET, BY CLINICAL PSG DEVICE, 2021-2028 (IN $ MILLION)
  • FIGURE 23: GLOBAL POLYSOMNOGRAPHY DEVICE (PSG) MARKET, BY AMBULATORY PSG DEVICE, 2021-2028 (IN $ MILLION)
  • FIGURE 24: GLOBAL DIAGNOSTICS AND MONITORING MARKET, BY OXIMETER, 2021-2028 (IN $ MILLION)
  • FIGURE 25: GLOBAL OXIMETER MARKET, BY TABLETOP OXIMETER, 2021-2028 (IN $ MILLION)
  • FIGURE 26: GLOBAL OXIMETER MARKET, BY FINGERTIP OXIMETER, 2021-2028 (IN $ MILLION)
  • FIGURE 27: GLOBAL OXIMETER MARKET, BY HANDHELD OXIMETER, 2021-2028 (IN $ MILLION)
  • FIGURE 28: GLOBAL OXIMETER MARKET, BY WRIST-WORN OXIMETER, 2021-2028 (IN $ MILLION)
  • FIGURE 29: GLOBAL DIAGNOSTICS AND MONITORING MARKET, BY ACTIGRAPHY MONITORING DEVICE, 2021-2028 (IN $ MILLION)
  • FIGURE 30: GLOBAL DIAGNOSTICS AND MONITORING MARKET, BY RESPIRATORY POLYGRAPH, 2021-2028 (IN $ MILLION)
  • FIGURE 31: GLOBAL DIAGNOSTICS AND MONITORING MARKET, BY SLEEP APNEA SCREENING DEVICE, 2021-2028 (IN $ MILLION)
  • FIGURE 32: GLOBAL DIAGNOSTICS AND MONITORING MARKET, BY OTHER DIAGNOSTICS AND MONITORING DEVICES, 2021-2028 (IN $ MILLION)
  • FIGURE 33: GLOBAL SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET, BY END-USER, IN 2020
  • FIGURE 34: GLOBAL SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET, BY HOSPITALS & SLEEP LABORATORIES, 2021-2028 (IN $ MILLION)
  • FIGURE 35: GLOBAL SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET, BY HOME CARE SETTINGS, 2021-2028 (IN $ MILLION)
  • FIGURE 36: NORTH AMERICA SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET, COUNTRY OUTLOOK, 2020 & 2028 (IN %)
  • FIGURE 37: UNITED STATES SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 38: CANADA SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 39: EUROPE SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET, COUNTRY OUTLOOK, 2020 & 2028 (IN %)
  • FIGURE 40: GERMANY SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 41: FRANCE SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 42: UNITED KINGDOM SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 43: ITALY SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 44: RUSSIA SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 45: BELGIUM SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 46: POLAND SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 47: REST OF EUROPE SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 48: ASIA-PACIFIC SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET, COUNTRY OUTLOOK, 2020 & 2028 (IN %)
  • FIGURE 49: CHINA SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 50: JAPAN SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 51: AUSTRALIA & NEW ZEALAND SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 52: INDIA SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 53: SOUTH KOREA SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 54: THAILAND SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 55: INDONESIA SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 56: VIETNAM SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 57: REST OF ASIA-PACIFIC SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 58: REST OF WORLD SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET, REGIONAL OUTLOOK, 2020 & 2028 (IN %)
  • FIGURE 59: LATIN AMERICA SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 60: MIDDLE EAST & AFRICA SLEEP APNEA THERAPEUTICS AND DIAGNOSTICS MARKET, 2021-2028 (IN $ MILLION)
Back to Top